Healthcare -
Biotechnology - NASDAQ - US
$ 1.775
-1.66 %
$ 86.8 M
Market Cap
-0.82
P/E
CABA - STOCK-BASED COMPENSATION
Stock-based Compensation CABA - Cabaletta Bio, Inc.
11.3 M
LAST VALUE
39.80%
2 YEAR CAGR
79.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR